JLIVE – Journal of Longevity
& Integrated Vitality Evidence
Search Results
Published Manuscripts
Open Access
Guest Editorial
Longevity Science at an Inflection Point: The Case for Integrative Vitality Evidence
JLIVE 2026, 1(1), 1; https://doi.org/10.59573/jlive.2026.2953 - 20 Jul 2026
Abstract Longevity science has matured from treating aging as an untouchable backdrop into a field that can measure and modify the biology of aging itself, driven by the hallmarks-of-aging framework, biomarkers and biological clocks, senotherapeutics, cellular reprogramming, the microbiome, and AI… Read more.
(This article belongs to the Section LONGEVITY SCIENCE)
Open Access
Review Article
Geroscience Biomarkers of Biological Age: Mapping the Hallmarks of Aging onto Biotic and Nutraceutical Endpoints in Longevity Trials
JLIVE 2026, 1(1), 2; https://doi.org/10.59573/jlive.2026.0102 - 21 Jul 2026
Abstract The convergence of Geroscience and precision medicine has catalyzed a paradigm shift in how we design, power, and interpret longevity clinical trials. Traditional disease-centric endpoints are increasingly giving way to validated biological aging markers—epigenetic clocks, telomere dynamics, SASP factors, and multi-omics aging indices… Read more.
(This article belongs to the Section GEROSCIENCE)